全文获取类型
收费全文 | 717篇 |
免费 | 44篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 23篇 |
妇产科学 | 3篇 |
基础医学 | 71篇 |
口腔科学 | 13篇 |
临床医学 | 103篇 |
内科学 | 167篇 |
皮肤病学 | 14篇 |
神经病学 | 57篇 |
特种医学 | 152篇 |
外科学 | 20篇 |
综合类 | 16篇 |
预防医学 | 38篇 |
眼科学 | 1篇 |
药学 | 93篇 |
肿瘤学 | 35篇 |
出版年
2022年 | 7篇 |
2021年 | 6篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 9篇 |
2015年 | 15篇 |
2014年 | 8篇 |
2013年 | 15篇 |
2012年 | 19篇 |
2011年 | 15篇 |
2010年 | 15篇 |
2009年 | 14篇 |
2008年 | 22篇 |
2007年 | 49篇 |
2006年 | 16篇 |
2005年 | 25篇 |
2004年 | 12篇 |
2003年 | 18篇 |
2002年 | 19篇 |
2001年 | 15篇 |
2000年 | 23篇 |
1999年 | 22篇 |
1998年 | 32篇 |
1997年 | 33篇 |
1996年 | 30篇 |
1995年 | 30篇 |
1994年 | 22篇 |
1993年 | 27篇 |
1992年 | 24篇 |
1991年 | 16篇 |
1990年 | 23篇 |
1989年 | 20篇 |
1988年 | 26篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 23篇 |
1984年 | 13篇 |
1983年 | 18篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 14篇 |
1976年 | 9篇 |
1975年 | 4篇 |
1962年 | 1篇 |
1959年 | 1篇 |
排序方式: 共有808条查询结果,搜索用时 15 毫秒
641.
Anand A. Joshi Soniya S. Vaidya Marie V. St-Pierre Andrei M. Mikheev Kelly E. Desino Abner N. Nyandege Kenneth L. Audus Jashvant D. Unadkat Phillip M. Gerk 《Pharmaceutical research》2016,33(12):2847-2878
The human placenta fulfills a variety of essential functions during prenatal life. Several ABC transporters are expressed in the human placenta, where they play a role in the transport of endogenous compounds and may protect the fetus from exogenous compounds such as therapeutic agents, drugs of abuse, and other xenobiotics. To date, considerable progress has been made toward understanding ABC transporters in the placenta. Recent studies on the expression and functional activities are discussed. This review discusses the placental expression and functional roles of several members of ABC transporter subfamilies B, C, and G including MDR1/P-glycoprotein, the MRPs, and BCRP, respectively. Since placental ABC transporters modulate fetal exposure to various compounds, an understanding of their functional and regulatory mechanisms will lead to more optimal medication use when necessary in pregnancy. 相似文献
642.
643.
苦参碱对细菌脂多糖诱导大鼠枯否细胞释放肿瘤坏死因子及白细胞介素-6的影响 总被引:19,自引:0,他引:19
目的是研究苦参碱对细菌脂多糖(lipopolysachrides,LPS)诱导经卡西霉素(calcimycin,Cal)预激活的大鼠枯否细胞分泌肿瘤坏死因子(tumornecrosisfactor,TNF)、白细胞介素6(interleukin6,IL6)的影响以及对小鼠体内产生TNF和IL6的影响。结果,苦参碱125,250及500mg·L-1剂量依赖性抑制大鼠枯否细胞分泌TNF和IL6;苦参碱50及100mg·kg-1降低小鼠体内TNF和IL6的水平。提示苦参碱的抗炎作用可能与其抑制TNF及IL6的产生有关。 相似文献
644.
1,4-Phenylenebis(methylene)selenocyanate (p-XSC) is an effective
chemopreventive agent against 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK)-induced lung adenoma in female A/J mice. While p-XSC can
effectively inhibit NNK-induced DNA methylation in female A/J mice and in
male F344 rats, its effect on NNK-induced oxidative DNA damage had not been
determined. Thus, the effect of p-XSC on the levels of 8-
hydroxy-2'-deoxyguanosine (8-OH-dG) in lung DNA from A/J mice and F344 rats
treated with NNK was examined. Mice were given NNK by gavage (0.5 mg/mouse
in 0.2 ml corn oil, three times per week for 3 weeks) or by a single i.p.
injection (2 mg/mouse in 0.1 ml saline) while maintained on a control diet
(AIN-76A) or control diet containing p-XSC at 10 or 15 p.p.m. (as Se)
starting 1 week before NNK administration and continuing until termination.
Mice were killed 2 h after the last NNK gavage in the multiple
administration protocol or 2 h after the single i.p. injection. Treatment
with NNK by gavage significantly elevated the levels of 8-OH-dG in lung DNA
of A/J mice from 0.7 +/- 0.1 to 1.6 +/- 0.2 adducts/10(5) 2'-deoxyguanosine
(dG) (P < 0.001), while dietary p- XSC (at 10 p.p.m. Se) prevented
significant elevation of the levels of this lesion caused by NNK, keeping
them at 0.9 +/- 0.1 adducts/10(5) dG (P < 0.003). Injection of NNK in
saline also significantly increased the levels of 8-OH-dG in lung DNA of
A/J mice from 1.2 +/- 0.6 to 3.6 +/- 0.8/10(5) dG adducts (P < 0.01),
while dietary p-XSC (at 15 p.p.m. Se) kept these levels at 1.9 +/- 0.5
adducts/10(5) dG (P < 0.03). Rats were given a single i.p. injection of
NNK (100 mg/kg body wt) in saline while being maintained on control diet
(AIN-76A) or control diet containing p-XSC (15 p.p.m. as Se) starting 1
week before NNK administration and continuing until termination. The rats
were killed 2 h after injection. Treatment with NNK using this protocol
significantly elevated the levels of 8-OH-dG in lung DNA of F344 rats from
2.6 +/- 0.5 to 3.5 +/- 0.5 adducts/10(5) dG (P < 0.03), while dietary
p-XSC (at 15 p.p.m. Se) kept the levels of this lesion at 2.2 +/- 0.6
adducts/10(5) dG (P < 0.01). Our findings suggest that the
chemopreventive efficacy of p-XSC against NNK-induced lung tumorigenesis in
A/J mice and F344 rats may be due in part to inhibition of oxidative DNA
damage.
相似文献
645.
苦参碱对脂多糖/痤疮丙酸杆菌诱导的小鼠肝炎及产生肿瘤坏死因子的影响 总被引:14,自引:0,他引:14
用小鼠致死性肝炎模型和TNF体外诱生的方法,研究苦参碱(Mat)对脂多糖(lipopolysaccharides,LPS)诱导的经痤疮丙酸杆菌(propionibacterittm acnes,PA)预刺激的小鼠产生肿瘤坏死因子(TNF)以及致死性肝炎的影响。结果表明:Mat(10,50mg·kg-1,ip,bid×3d)可降低血清TNF和ALT水平及小鼠对LPS致死毒性的敏感性,并可在体外抑制LPS诱导的经PA预刺激的小鼠腹腔巨噬细胞释放TNF。提示Mat的保肝作用与其抑制TNF释放有关。 相似文献
646.
Brisson D Ledoux K Bossé Y St-Pierre J Julien P Perron P Hudson TJ Vohl MC Gaudet D 《Pharmacogenetics》2002,12(4):313-320
647.
Minor products of reaction of DNA with alpha-acetoxytamoxifen 总被引:1,自引:0,他引:1
The drug tamoxifen shows evidence of genotoxicity and induces liver tumours
in rats. Covalent DNA adducts have been detected in the liver of rats
treated with tamoxifen and these arise, at least in part, from its
metabolite alpha-hydroxytamoxifen. This probably undergoes conjugation in
the liver tissue to give an ester, which alkylates DNA. We have prepared
alpha-acetoxytamoxifen as a model for this reactive intermediate and
studied its reaction with DNA in vitro. The products of this reaction were
chromatographically identical to DNA adducts found in the liver of rats
treated with tamoxifen. We have isolated three of these products as the
nucleosides TG1, TG2 and TA1 and identified them by ultraviolet, mass and
proton magnetic resonance spectroscopy. TG1 and TG2 were
tamoxifen-deoxyguanosine adducts in which the alpha-position of tamoxifen
was linked to the amino group of guanine; TG1,
(E)-4-[4-[2-(dimethylamino)ethoxy]phenyl]-3,4-diphenyl-2- (9beta-de
oxyribofuranosyl-6-oxopurin-2-ylamino)-3-butene; TG2, (Z) isomer of TG1. In
TG2, the tamoxifen group had undergone trans-cis isomerization. The minor
product TA1 was a tamoxifen-deoxyadenosine adduct, where linkage was
through the amino group of adenine: (E)-4-[4- [2-(dimethylamino)
ethoxy]phenyl]-3,4-diphenyl-2-(9beta- deoxyribofuranosylpurin
-6-ylamino)-3-butene. These three adducts accounted for >90% of the
reaction products (approximately 67% TG1, 18% TG2 and 7% TA1); trace
products included other stereoisomers of these and dinucleotide adducts
which resisted enzymatic digestion.
相似文献
648.
Prokopczyk B; Amin S; Desai DH; Kurtzke C; Upadhyaya P; El-Bayoumy K 《Carcinogenesis》1997,18(9):1855-1857
We reported earlier that continuous feeding of 1,4-
phenylenebis(methylene)selenocyanate (p-XSC) inhibited lung tumor induction
by the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-
(3-pyridyl)-1-butanone (NNK) in the A/J mouse (El-Bayoumy et al.,
Carcinogenesis, 14, 1111-1113, 1993). The present investigation was
designed to determine whether p-XSC inhibits pulmonary neoplasia induced by
NNK in female A/J mice during the initiation phase of carcinogenesis or
during the post-initiation phase. The naturally occurring selenomethionine
was also included in this study. Doses higher than 4 p.p.m. of
selenomethionine can induce toxic effects, therefore, dietary
supplementation of this compound was selected at a dose level of 3.75
p.p.m. However, we were able to give p-XSC at selenium levels of 7.5 and 15
p.p.m., as mice can tolerate such doses in this form without any adverse
effects. NNK was given by a single i.p. injection at dose of 10 micromol in
0.1 ml of saline. Selenomethionine did not show chemopreventive activity
when administered in either phase of tumorigenesis. In contrast, p-XSC
significantly reduced lung tumor multiplicity regardless of whether it was
given during the initiation phase of tumorigenesis (P = 0.0009 at both
levels of selenium) or post-initiation (P = 0.0009 at 15 p.p.m. and P =
0.036 for 7.5 p.p.m.). This is the first report describing that the
synthetic organoselenium compound, p-XSC, can effectively block and
suppress chemically (NNK)-induced lung tumor development in mice.
相似文献
649.
M Mimeault R Quirion Y Dumont S St-Pierre A Fournier 《Journal of medicinal chemistry》1992,35(12):2163-2168
A structure-activity study was carried out to determine the importance of the N-terminal amino acids of hCGRP8-37 in binding and antagonistic activity to CGRP receptors. Therefore, fragments of hCGRP8-37 as well as analogs obtained by the replacement of residues 9-12 by L-alanine were synthesized by solid-phase peptide synthesis, using BOP as a coupling reagent. The affinities of the peptides to CGRP receptors were evaluated in the rat brain, guinea pig atrium, and guinea pig vas deferens membrane preparations. Their antagonistic activities were measured in the guinea pig atria and rat vas deferens bioassays. The pharmacological characterization showed that arginine-11 and leucine-12 play a crucial role for the affinity of hCGRP8-37. Interestingly, it was observed that [Ala11]hCGRP8-37 was able to potentiate the twitch response of the electrically stimulated rat vas deferens. On the other hand, the substantial antagonistic potencies of analogs [Ala9]-, [Ala10]-, and [Ala12]hCGRP8-37, as compared to those of the fragments hCGRP10-37, hCGRP11-37, and hCGRP12-37, suggest that the side chains of Thr-9, His-10, and Leu-12 assume mainly a structural role. Accordingly, the conformational characterization of these peptides by circular dichroism spectroscopy revealed that the residues 9-12 are important for the integrity of the amphiphilic alpha-helix of hCGRP8-37. 相似文献
650.
Lemieux P Vinogradov SV Gebhart CL Guérin N Paradis G Nguyen HK Ochietti B Suzdaltseva YG Bartakova EV Bronich TK St-Pierre Y Alakhov VY Kabanov AV 《Journal of drug targeting》2000,8(2):91-105
Self-assembling complexes from nucleic acids and synthetic polymers are evaluated for plasmid and oligonucleotide (oligo) delivery. Polycations having linear, branched, dendritic. block- or graft copolymer architectures are used in these studies. All these molecules bind to nucleic acids due to formation of cooperative systems of salt bonds between the cationic groups of the polycation and phosphate groups of the DNA. To improve solubility of the DNA/polycation complexes, cationic block and graft copolymers containing segments from polycations and non-ionic soluble polymers, for example, poly(ethylene oxide) (PEO) were developed. Binding of these copolymers with short DNA chains, such as oligos, results in formation of species containing hydrophobic sites from neutralized DNA polycation complex and hydrophilic sites from PEO. These species spontaneously associate into polyion complex micelles with a hydrophobic core from neutralized polyions and a hydrophilic shell from PEO. Such complexes are very small (10-40 nm) and stable in solution despite complete neutralization of charge. They reveal significant activity with oligos in vitro and in vivo. Binding of cationic copolymers to plasmid DNA forms larger (70-200 nm) complexes. which are practically inactive in cell transfection studies. It is likely that PEO prevents binding of these complexes with the cell membranes ("stealth effect"). However attaching specific ligands to the PEO-corona can produce complexes, which are both stable in solution and bind to target cells. The most efficient complexes were obtained when PEO in the cationic copolymer was replaced with membrane-active PEO-b-poly(propylene oxide)-b-PEO molecules (Pluronic 123). Such complexes exhibited elevated levels of transgene expression in liver following systemic administration in mice. To increase stability of the complexes, NanoGel carriers were developed that represent small hydrogel particles synthesized by cross-linking of PEI with double end activated PEO using an emulsification/solvent evaporation technique. Oligos are immobilized by mixing with NanoGel suspension, which results in the formation of small particles (80 nm). Oligos incorporated in NanoGel are able to reach targets within the cell and suppress gene expression in a sequence-specific fashion. Further. loaded NanoGel particles cross-polarized monolayers of intestinal cells (Caco-2) suggesting potential usefulness of these systems for oral administration of oligos. In conclusion the approaches using polycations for gene delivery for the design of gene transfer complexes that exhibit a very broad range of physicochemical and biological properties, which is essential for design of a new generation of more effective non-viral gene delivery systems. 相似文献